Wang X M, Tresham J J, Congiu M, Scoggins B A, Coghlan J P
Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, Australia.
Acta Endocrinol (Copenh). 1989 Mar;120(3):369-73. doi: 10.1530/acta.0.1200369.
The role of opioids in the regulation of arginine vasopressin release from the posterior pituitary is a subject of controversy. In the present study, we examined the effects of central administration of met-enkephalin, leu-enkephalin, the enkephalin analogue FK-33824, and the opiate antagonist naloxone, and the effects of systemic administration of met-enkephalin and FK-33824 on AVP secretion in conscious normal sheep. Intracerebroventricular infusion of FK-33824 significantly increased the plasma concentration of immunoreactive AVP in a dose-dependent manner, but met-enkephalin, leu-enkephalin and naloxone failed to change plasma concentration of AVP. Intravenous infusion of met-enkephalin and FK-33824 also failed to change plasma concentration of AVP. The opiate antagonist naloxone given both centrally and systemically attenuated the increase in plasma concentration of AVP induced by FK-33824. We conclude that basal AVP release is stimulated by central administration of FK-33824.
阿片类药物在调节垂体后叶精氨酸血管加压素释放中的作用是一个有争议的话题。在本研究中,我们研究了向清醒正常绵羊脑室内注射甲硫氨酸脑啡肽、亮氨酸脑啡肽、脑啡肽类似物FK - 33824以及阿片拮抗剂纳洛酮的效果,以及静脉注射甲硫氨酸脑啡肽和FK - 33824对血管加压素分泌的影响。脑室内注入FK - 33824以剂量依赖方式显著增加了免疫反应性血管加压素的血浆浓度,但甲硫氨酸脑啡肽、亮氨酸脑啡肽和纳洛酮未能改变血管加压素的血浆浓度。静脉注射甲硫氨酸脑啡肽和FK - 33824也未能改变血管加压素的血浆浓度。脑室内和静脉内给予阿片拮抗剂纳洛酮均减弱了FK - 33824诱导的血管加压素血浆浓度升高。我们得出结论,脑室内注射FK - 33824可刺激基础血管加压素释放。